Press Release
Akebia Therapeutics Announces Initiation of Phase 2b Trial of Oral Anemia Candidate
Akebia Therapeutics Announces Initiation of Phase 2b Trial of Oral Anemia Candidate
July 24, 2013 at 12:00 AM EDT
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax